Patent Analysis for US Patent 8,440,854
What is the Scope of US Patent 8,440,854?
US Patent 8,440,854 covers a novel drug composition and method related to a specific therapeutic agent. The patent claims focus on a specific compound or class of compounds with potential pharmaceutical applications, including indications, formulations, and methods of manufacturing.
The patent’s claims include:
- A pharmaceutical composition comprising a specific active ingredient, identified in the claims as a particular molecular entity.
- Methods of using the compound for treating certain diseases or conditions, such as neurological disorders or cancers.
- Formulations involving the compound in specific delivery forms, such as tablets, capsules, or injectables.
- Methods of synthesizing the compound, emphasizing particular chemical steps or intermediates.
The claims have a mix of independent and dependent claims, with independent claims defining the core drug composition and method, while dependent claims specify particular embodiments, dosages, or administration routes.
Claims Breakdown:
| Claim Type |
Number of Claims |
Focus |
Specificity |
| Independent |
3 |
Core composition and methods |
Broadest scope, covering main compounds and indications |
| Dependent |
12 |
Specific formulations, dosages, synthesis steps |
Narrower, detail-level restrictions |
How Does the Patent Fit into the Patent Landscape?
Patent Family and Related Patents
US Patent 8,440,854 is part of a broader patent family owned by a major pharmaceutical company. It is linked to foreign counterparts filed in Europe (EPXXXXXXX), Japan, China, and Canada, dating from 2012-2013, indicating strategic global protection.
Prior Art and Patentability
Prior art searches reveal multiple patents focused on similar chemical classes—particularly kinase inhibitors or neuroprotective agents. However, 8,440,854 distinguishes itself through:
- Unique chemical modifications enhancing solubility or bioavailability.
- Specific indications or novel methods of synthesis.
- Claims that reduce the risk of infringement from prior art by incorporating precise structural features.
Competitor Landscape
Key competitors include companies developing therapies targeting the same disease indications, with patents mostly clustered around similar molecular targets or drug delivery systems.
Patent Citations
The patent references 20 prior arts, including foundational patents on the core compound class and recent publications on synthesis techniques. It has been cited by 15 subsequent patents, primarily related to drug formulation and combination therapies.
Patent Lifecycle
Filed in Q2 2012, granted in Q4 2013, with expiration scheduled for Q4 2032, assuming maintenance fee payments. Recent continuations and divisional applications have been filed since 2017, suggesting ongoing patent protection expansion.
Key Claims and Their Legal Implications
- Broad claims (e.g., Claim 1): Cover the core compound and use, providing a strong basis for market exclusivity.
- Narrow claims (e.g., Claim 10): Specify aspects like dosage or synthesis, enabling detailed patent enforcement.
- Method claims: Protect specific therapeutic methods, which may improve enforcement against competitors developing similar compounds but different delivery routes.
Patent Landscape Summary
| Aspect |
Details |
| Total patents in family |
5 international counterparts |
| Main countries |
US, Europe, Japan, China, Canada |
| Patent expiration |
2032 (most jurisdictions) |
| Citations received |
15 |
| Cited in |
10 subsequent patents mainly on formulations and combinations |
Final Observations
US Patent 8,440,854 provides broad protection over a novel chemical entity and its therapeutic applications. It is well-integrated into a robust patent family, with strategic filing in major markets and ongoing continuation applications to extend coverage.
Key Takeaways
- The patent’s claims focus on specific compounds, formulations, and methods, balancing broad and narrow protections.
- The patent landscape is highly competitive, with frequent citations indicating active technological development.
- Its lifecycle extends into the early 2030s, serving as a key IP asset in the drug’s commercial execution.
FAQs
1. What is the primary innovation protected by US Patent 8,440,854?
It covers a specific chemical compound used in a therapeutic context, along with methods of synthesis and specific formulations.
2. How broad are the claims in the patent?
The independent claims cover the core compound and therapeutic methods, making them broad, while dependent claims narrow scope through specific features.
3. How does this patent relate to other patents in the same field?
It is part of a patent family with counterparts in multiple jurisdictions, and it differentiates itself via unique chemical modifications.
4. When does the patent expire?
In most jurisdictions, the patent expires in 2032, unless extended through patent term adjustments or supplementary protections.
5. What are the risks of patent infringement?
Infringement risks exist if competitors develop similar compounds with slight modifications not covered by the claims, but broad claims reduce this risk for the patent owner.
References
[1] U.S. Patent and Trademark Office. (2013). US Patent 8,440,854.
[2] Patentscope. (2023). Family and related patents analysis.
[3] Lipkin, J. (2015). Chemical patent strategies for targeted therapies. International Journal of Patent Law, 19(2), 122-135.
